Literature DB >> 12461592

Acremonium strictum pulmonary infection in a leukemic patient successfully treated with posaconazole after failure of amphotericin B.

R Herbrecht1, V Letscher-Bru, C Fohrer, F Campos, S Natarajan-Ame, A Zamfir, J Waller.   

Abstract

A severely neutropenic patient with chronic lymphocytic leukemia developed a diffuse bilateral pulmonary infection while receiving a therapeutic daily dosage of intravenous amphotericin B for Candida glabrata esophagitis. Computed tomography of the chest showed numerous lung nodules, ground glass areas and a pleural effusion. Biopsy of one nodule demonstrated hyaline septate hyphae. Multiple sputum cultures grew Acremonium strictum. Increasing the dose of amphotericin B and the addition of itraconazole did not resolve the infection. Change of treatment to posaconazole given orally at 200 mg four times/d resulted in progressive improvement leading finally to cure after 24 weeks of therapy. Treatment with posaconazole was clinically and biologically well tolerated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12461592     DOI: 10.1007/s10096-002-0828-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  12 in total

Review 1.  Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.

Authors:  M A Pfaller; D J Diekema
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

2.  Acremonium strictum: Report of a Rare Emerging Agent of Cutaneous Hyalohyphomycosis with Review of Literatures.

Authors:  Ajanta Sharma; N K Hazarika; Purnima Barua; M R Shivaprakash; Arunaloke Chakrabarti
Journal:  Mycopathologia       Date:  2013-10-12       Impact factor: 2.574

3.  Acremonium strictum fungaemia in a paediatric immunocompromised patient: diagnosis and treatment difficulties.

Authors:  Hikombo Hitoto; Marc Pihet; Béatrice Weil; Dominique Chabasse; Jean-Philippe Bouchara; Petronella Rachieru-Sourisseau
Journal:  Mycopathologia       Date:  2010-03-26       Impact factor: 2.574

Review 4.  Acremonium species: a review of the etiological agents of emerging hyalohyphomycosis.

Authors:  Shukla Das; Rumpa Saha; Sajad Ahmad Dar; V G Ramachandran
Journal:  Mycopathologia       Date:  2010-06-25       Impact factor: 2.574

Review 5.  Posaconazole.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 6.  Newer systemic antifungal agents : pharmacokinetics, safety and efficacy.

Authors:  Helen W Boucher; Andreas H Groll; Christine C Chiou; Thomas J Walsh
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Evaluation of the efficacies of Amphotericin B, Posaconazole, Voriconazole, and Anidulafungin in a murine disseminated infection by the emerging opportunistic Fungus Sarocladium (Acremonium) kiliense.

Authors:  Fabiola Fernández-Silva; Javier Capilla; Emilio Mayayo; Deanna A Sutton; Pilar Hernández; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2013-10-07       Impact factor: 5.191

8.  A Rare Case of Brain Abscesses Caused by Acremonium Species.

Authors:  Armeena Anis; Fnu Sameeullah; Jamil M Bhatti
Journal:  Cureus       Date:  2021-04-10

9.  Acremonium Pneumonia: Case Report and Literature Review.

Authors:  Atefeh Fakharian; Atosa Dorudinia; Ilad Alavi Darazam; Davood Mansouri; Mohammad Reza Masjedi
Journal:  Tanaffos       Date:  2015

10.  MIC Distributions and Evaluation of Fungicidal Activity for Amphotericin B, Itraconazole, Voriconazole, Posaconazole and Caspofungin and 20 Species of Pathogenic Filamentous Fungi Determined Using the CLSI Broth Microdilution Method.

Authors:  Andrew M Borman; Mark Fraser; Michael D Palmer; Adrien Szekely; Marian Houldsworth; Zoe Patterson; Elizabeth M Johnson
Journal:  J Fungi (Basel)       Date:  2017-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.